Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Abeona Therapeutics Inc. buy melinda

Start price
€192.50
11.08.17 / 50%
Target price
€250.00
24.08.17
Performance (%)
23.05%
End price
€236.88
24.08.17
Summary
This prediction ended on 24.08.17 with a price of €236.88. The BUY prediction by melinda finished with a performance of 23.05%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Abeona Therapeutics Inc. 2.251% 2.251% 181.600% -81.492%
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

According to melinda what are the pros and cons of Abeona Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Abeona Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 23.05%
Target price 10.000
Change
Ends at 24.08.17

$

Prediction Buy
Perf. (%) 23.05%
Target price 10.000
Change
Ends at 24.08.17

(Vom Mitglied beendet)

Stopped prediction by melinda for Abeona Therapeutics Inc.

buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.80
24.10.22
€4.50
24.10.23
-3.11%
25.10.23

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.80
17.10.21
€25.00
17.10.22
-15.53%
26.11.21

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€49.50
22.03.20
€75.00
04.11.21
-60.00%
17.10.21

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€36.50
14.03.20
€62.50
22.03.20
23.29%
22.03.20

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€76.00
15.02.20
€200.00
14.03.20
-51.97%
14.03.20

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€136.09
26.05.19
€180.40
15.02.20
-44.15%
15.02.20

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€158.98
28.02.19
€270.60
12.03.19
9.36%
12.03.19

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€157.17
01.01.19
€214.23
28.02.19
1.15%
28.02.19

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€376.59
22.05.18
€483.70
31.05.18
4.94%
31.05.18

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€273.98
14.02.18
€383.35
19.03.18
23.05%
19.03.18

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€284.13
13.02.18
€383.35
14.02.18
-9.92%
14.02.18

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€420.56
06.10.17
€451.00
10.10.17
7.28%
10.10.17

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€277.37
30.08.17
€563.75
18.09.17
34.96%
18.09.17

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€307.50
30.08.17
€625.00
18.09.17
34.96%
18.09.17

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€173.64
11.08.17
€225.50
24.08.17
23.05%
24.08.17

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€110.50
27.01.17
€225.50
07.04.17
3.57%
07.04.17

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€55.25
13.07.16
€60.89
29.07.16
10.61%
29.07.16

Could be worthwhile Investment >10% per year